FdaApplication
NDA 022271
Identifiers
- fda_app_no: NDA022271
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2013-01-25 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NESINA | ALOGLIPTIN BENZOATE | EQ 25MG BASE | TABLET;ORAL |
| NESINA | ALOGLIPTIN BENZOATE | EQ 12.5MG BASE | TABLET;ORAL |
| NESINA | ALOGLIPTIN BENZOATE | EQ 6.25MG BASE | TABLET;ORAL |
3 products